Recommendations on how to ensure the safety and effectiveness of biosimilars in Latin America: a point of view
Crossref DOI link: https://doi.org/10.1007/s10067-015-2887-0
Published Online: 2015-02-12
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pineda, Carlos
Caballero-Uribe, Carlo V.
de Oliveira, Marcia Gonclaves
Lipszyc, Pedro Saul
Lopez, Jose Julian
Mataos Moreira, Marcelo Mario
Azevedo, Valderilio Feijo
License valid from 2015-02-12